Pre-Menopausal and Post-Menopausal Depressed Women

References

• Weissman M., Klerman G. Sex differences and the epidemiology of depression. Archives of General Psychiatry 1977; 34: 98–111
   PubMed Web of Science ®Google Scholar
• Merikangas K., Weissman M., Pauls D. Genetic factors in the sex ratio of major depression. Psychological Medicine 1985; 15: 63–9
   PubMedGoogle Scholar
• Kraepelin E. Manic-depressive Insanity and Paranoia, translation of Lehrbuchder Psychiatrie, 8th edn, R. Barclay. Edinburgh. 1921
   Google Scholar
• Kendell R. The Classification of Depressive Illness. Oxford University Press, Oxford 1968
   Google Scholar
• Kaplan H., Freedman A., Sadock B. Comprehensive Textbook of Psychiatry2nd edn. Williams and Wilkins, Baltimore 1975
   Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders2nd edn. Washington, DC 1970
   Google Scholar
• Kaplan H., Freedman A., Sadock B. Comprehensive Textbook of Psychiatry3rd edn. Williams and Wilkins, Baltimore 1980
   Google Scholar
• AMERICAN PSYCHIATRIC ASSOCIATION. Diagnostic and Statistical Manual of Mental Disorders3rd edn. Washington, DC 1980
   Google Scholar
• Sachar E. J., Schalch D. S., Reichlin S., Platman D. Endocrinology of depression: II. Plasma gonadotrophins in depressive illness: a preliminary report. Recent Advances in the Psychobiology of the Depressive Illnesses, T. A. Williams, M. M. Katz, J. A. Shields, Washington, DC 1972; 229–33, DHEW Publication No. 770–9053
   Google Scholar
• Altman N., Sachar E. J., Gruen P. H., et al. Reduced plasma Lh concentration in postmenopausal depressed women. Psychosomatic Medicine 1975; 37: 274–6
   PubMed Web of Science ®Google Scholar
• Amsterdam J., Winokur A., Lucki I., Synder P. Neuroendocrine regulation in depressed postmenopausal women and healthy subjects. Acta Psychiatrica Scandinavica 1983; 67: 43–9
   Google Scholar
• Luine V., Khylchevskaya R., McEwen B. Effect of gonadal steroids on activities of monoamine oxidase and choline acetylase in rat brain. Brain Research 1975; 86: 293–306
   PubMed Web of Science ®Google Scholar
• Anton-Tay F., Wurtman R. Norepinephrine: turnover in rat brains after gonadectomy. Science 1968; 159: 1245
   PubMedGoogle Scholar
• Anton-Tay F., Anton S., Wurtman R. Mechanism of changes in brain norepinephrine metabolism after overiectomy. Neuroendocrinology 1970; 6: 265–73
   Google Scholar
• Wirz-Justice A., Hackman E., Lichsteiner M. The effect of oestradiol dipropionate and progesterone on monoamine uptake in rat brain. Journal of Neurochemistry 1974; 22: 187–9
   Google Scholar
• Raymond V., Beaulieu M., Labrie F., Boissier J. Potent antidopaminergic activity of oestradiol at the pituitary level on prolactin release. Science 1978; 200: 1174–5
   Google Scholar
• Halbreich U., Vital-Herne J., Goldstein S., Zander K. Sex differences in biological factors putatively related to depression. Journal of Affective Disorders 1984; 7: 1223–33
   Google Scholar
• Williams L., Lefkowitz R. Regulation of rabbit myometrial s-adrenergic receptors by estrogen and progesterone. Journal of Clinical Investigation 1977; 60: 815–18
   Google Scholar
• Fischette C., Bigeon A., McEwen B. Sex differences in serotonin receptor binding in rat brain. Science 1983; 222: 333–5
   PubMed Web of Science ®Google Scholar
• Zolovick A., Pearse R., Boehlke K., Eleftheriou B. Monoamine oxidase activity in various parts of the rat brain during the oestrous cycle. Science 1966; 154: 649
   Google Scholar
• Stefano F., Donoso A. Norepinephrine levels in rat hypothalamus during the estrous cycle. Endocrinology 1967; 8: 1405–6
   Google Scholar
• Janowsky D. S., Davis J. M. Progesteron-estrogen effects on uptake and release of norepinephrine by synaptosomes. Life Sciences 1967; 9: 525–31
   Google Scholar
• Donoso A., Cuckier J. Oestrogen as depressor of noradrenaline concentrations in the anterior hypothalamus. Nature 1968; 218: 969–70
   Google Scholar
• Klaiber E., Broverman D., Vogel W., et al. Estrogen therapy for severe persistent depressions in women. Archives of General Psychiatry 1979; 36: 550–60
   PubMed Web of Science ®Google Scholar
• Shapira B., Oppenheim G., Zohar J., et al. Lack of efficacy of estrogen supplementation to imipramine in resistant female depressives. Biological Psychiatry 1985; 20: 570–83
   PubMedGoogle Scholar
• Holsboer F., Benkert O., Meier L., Kreuz-Kersting A. Combined estradial and vitamin B6 treatment in women with major depression. American Journal of Psychiatry 1985; 142: 658
   Google Scholar
• Roy A., Jimerson D., Pickar D. Plasma 3-methoxy-4-hydroxy-phenylethyleneglycol in depressive disorders. American Journal of Psychiatry 1986; 143: 846–51
   Google Scholar
• Roy A., Pickar D., Linnoila M., Potter W. Plasma norepinephrine in affective disorders: relationship to melancholia. Archives of General Psychiatry 1985; 42: 1181–5
   Google Scholar
• Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 1960; 23: 56–62
   PubMed Web of Science ®Google Scholar
• Seppala T., Scheinin M., Capone A., Linnoila M. Liquid chromatographic assay for CSF catecholamines using electrochemical detection. Acta Pharmacologica et Toxicologica 1984; 55: 81–7
   Google Scholar
• Jimerson D. C., Markey S. P., Oliver J. O., Kopin I. J. Simultaneous measurement of plasma 4-hydroxy-3-methoxyphenylethyleneglycol and 3,4-dihydroxyphenylethyleneglycol by gas chromatography-mass spectrometry. Biomedical Mass Spectrometry 1981; 8: 256–9
   PubMedGoogle Scholar
• Carroll B. J., Feinberg M., Greden J. F., et al. A specific laboratory test for the diagnosis of melancholia: standardization, validation, and clinical utility. Archives of General Psychiatry 1981; 38: 15–22
   PubMed Web of Science ®Google Scholar
• Paykel E., Emms E., Fletcher J., Rassaby E. Life events and social supports in puerperal depression. British Journal of Psychiatry 1980; 136: 339–46
   PubMed Web of Science ®Google Scholar
• Paykel E., McGuiness B., Gomez J. An Anglo-American comparison of the scaling of life events. British Journal of Medical Psychology 1976; 49: 237–47
   PubMed Web of Science ®Google Scholar
• Roy A., Breier A., Doran A., Pickar D. Life events in depression: relationship to subtypes. Journal of Affective Disorders 1985; 9: 143–8
   PubMedGoogle Scholar
• Kopin I. Avenues of investigation for the role of catecholamines in anxiety. Psychopathology 1984; 17: 83–97
   Google Scholar
• Blombery P., Kopin I., Gordon E., et al. Conversion of Mhpg to vanillylmandelic acid: implications for the importance of urinary Mhpg. Archives of General Psychiatry 1980; 37: 1095–8
   PubMed Web of Science ®Google Scholar
• Leckman J., Maas J. Plasma MHPG: relationship to brain noradrenergic systems and emerging clinical applications. Neurobiology of Mood Disorders, R. Post, J. Ballenger. Williams and Wilkins, Baltimore 1984; 529–38
   Google Scholar
• Jimerson D., Ballenger J., Lake R., et al. Plasma and Csf Mhpg in normals. Psychopharmacology Bulletin 1981; 17: 86–7
   Google Scholar
• Siever L., Pickar D., Lake C., et al. Extreme elevations in plasma norepinephrine associated with decreased s-adrenergic responsivity: two case reports. Journal of Clinical Psychopharmacology 1983; 3: 39–41
   Google Scholar
• Goldstein D., Lake C., Chernow B., et al. Age dependence of hypertensive-normotensive differences in plasma norepinephrine. Hypertension 1983; 5: 100–4
   PubMed Web of Science ®Google Scholar
• Feldman R. s-Adrenergic receptor regulation in human leucocytes: physiological, pharmacological and pathological correlates. Seminar National Institute of Mental Health, Bethesda, Maryland July, 1985
   Google Scholar
• Roy A., Pickar D., Paul S. Biologic tests in depression. Psychosomatics 1984; 25: 443–8
   PubMed Web of Science ®Google Scholar
• Asnis G., Sachar E., Halbreich V., et al. Cortisol secretion in relation to age in major depression. Psychosomatic Medicine 1981; 43: 235–42
   PubMed Web of Science ®Google Scholar
• Stokes P., Stoll P., Koslow S., et al. Pretreatment Dst and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. Archives of General Psychiatry 1984; 41: 257–67
   PubMed Web of Science ®Google Scholar
• Oxenbrug G., Nunzio P., McIntyre I., et al. Aging and cortisol resistance to suppression by dexamethasone: a positive correlation. Psychiatry Research 1983; 10: 125–30
   Google Scholar
• Rubin L., Price L., Charney D., Heninger G. Noradrenergic function and the cortisol response to dexamethasone in depression. Psychiatry Research 1985; 15: 5–15
   PubMed Web of Science ®Google Scholar
• Rosenbaum A., Schatzerg A., Maclaughlin R., et al. The dexamethasone suppression test in normal control subjects: comparison of two assays and effect of age. American Journal of Psychiatry 1984; 141: 1550–5
   Google Scholar
• Halbreich U., Asnis G., Zumoff B., et al. Effect of age and sex on cortisol secretion in depressive and normals. Psychiatry Research 1984; 13: 221–9
   PubMed Web of Science ®Google Scholar
• Lewis D., Pfohl B., Schlechte J., Coryell W. Influence of age on the cortisol response to dexamethasone. Psychiatry Research 1984; 13: 213–20
   Google Scholar
• Vale W., Spiess J., Rivier C., et al. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and s-endorphin. Science 1982; 213: 1394–7
   Google Scholar
• Gold P., Loriaux L., Roy A., et al. Responses to corticotropin releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications. New England Journal of Medicine 1986; 314: 1330–5
   Google Scholar
• Weiner R., Ganong W. Role of brain monoamines and histamine in regulation of anterior pituitary secretion. Physiological Reviews 1978; 58: 905
   PubMed Web of Science ®Google Scholar
• Robinson D., Sourkes T., Nies A. Monoamine metabolism in human brain. Archives of General Psychiatry 1977; 34: 89–92
   PubMed Web of Science ®Google Scholar
• Brown M., Fisher L., Spiess J., et al. Corticotropin releasing factor: actions on the sympathetic nervous system and metabolism. Endocrinology 1982; 111: 928–31
   PubMed Web of Science ®Google Scholar
• Bowers M., Gerbode F. The relationship of monoamine metabolites in human cerebrospinal fluid to age. Nature 1968; 219: 1256–7
   Google Scholar
• Asberg M., Bertilsson L. Serotonin in depressive illness: studies of CSF 5-HIAA. Neuro-psychopharmacology, B. Saletu. Pergamon Press, New York 1979; 105–15
   Google Scholar
• Asberg M., Bertilsson L., Thoren P., . Csf monoamine metabolites in depressive illness. Depressive Disorders, S. Garattini, et al. Friedrich-Karl Schattauer Verlag, Stuttgart, 293–305
   Google Scholar
• Gottfries G., Gottfries I., Johansson B., et al. Acid monoamine metabolites in human cerebrospinal fluid and their relations to age and sex. Neuropharmacology 1971; 10: 665–72
   PubMedGoogle Scholar
• Traskman L., Asberg M., Bertilsson L., Sjostrand L. Monoamine metabolites in CSF and suicidal behavior. Archives of General Psychiatry 1981; 38: 631–6
   PubMed Web of Science ®Google Scholar
• Koslow S. H., Maas J. W., Bowden C. L., et al. Csf and urinary biogenic amines and metabolites in depression and mania: a controlled, univariate analysis. Archives of General Psychiatry 1983; 40: 999
   PubMed Web of Science ®Google Scholar
• Gerner R., Fairbanks L., Anderson G., et al. Csf neurochemistry in depressed, manic and schizophrenic patients compared with that in normal controls. American Journal of Psychiatry 1984; 141: 1533–40
   PubMedGoogle Scholar
• Muscettola G., Potter W., Pickar D., Goodwin F. Urinary 3-methoxy-4-hydroxyphenylglycol and major affective disorders. Archives of General Psychiatry 1984; 41: 337–41
   Google Scholar
• Roy A., Pickar D., Douillet P., Karoum F., Linnoila M. Urinary monoamines and monoamine metabolites in subtypes of unipolar depressive disorder and normal controls. Psychological Medicine 1985; 16: 541–6
   Google Scholar
• Jimerson D., Rubinow D., Ballenger J., . Cerebrospinal fluid norepinephrine metabolites in depressed patients: new methodologies. Catecholamines: Neuropharmacology and Central Nervous System — Therapeutic Aspects, G. Usdin, A. Carlsson, A. Dahlstrom, J. Engel, et al. Alan Liss Inc., New York, 123–9
   Google Scholar
• Paykel E. Recent life events in the development of the depressive disorders. The Psychobiology of the Depressive Disorders. Implications for the Effects of Stress, R. Dupue. Academic Press, New York 1979; 245–62
   Google Scholar
• Paykel E. Contribution of life events to causation of psychiatric illness. Psychological Medicine 1978; 8: 245–53
   PubMed Web of Science ®Google Scholar
• Roy A., Pickar D., Linnoila M., et al. Cerebrospinal fluid monoamine and monoamine metabolites in melancholia. Psychiatry Research, 15: 281–92
   Google Scholar